BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Preet S, Bharati S, Panjeta A, Tewari R, Rishi P. Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis--a possible adjunct therapy. Tumour Biol 2015;36:8301-8. [PMID: 26002579 DOI: 10.1007/s13277-015-3571-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen T, Brody H, Lin GH, Rangé H, Kuraji R, Ye C, Kamarajan P, Radaic A, Gao L, Kapila Y. Probiotics, including nisin-based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases. Periodontol 2000 2020;82:173-85. [PMID: 31850634 DOI: 10.1111/prd.12324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
2 Rana K, Kumar Pandey S, Chauhan S, Preet S. Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. International Journal of Pharmaceutics 2022;620:121744. [DOI: 10.1016/j.ijpharm.2022.121744] [Reference Citation Analysis]
3 Sultana A, Luo H, Ramakrishna S. Antimicrobial Peptides and Their Applications in Biomedical Sector. Antibiotics (Basel) 2021;10:1094. [PMID: 34572676 DOI: 10.3390/antibiotics10091094] [Reference Citation Analysis]
4 Jančič U, Gorgieva S. Bromelain and Nisin: The Natural Antimicrobials with High Potential in Biomedicine. Pharmaceutics 2021;14:76. [PMID: 35056972 DOI: 10.3390/pharmaceutics14010076] [Reference Citation Analysis]
5 Chauhan S, Dhawan DK, Saini A, Preet S. Antimicrobial peptides against colorectal cancer-a focused review. Pharmacol Res 2021;167:105529. [PMID: 33675962 DOI: 10.1016/j.phrs.2021.105529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Preet S, Pandey SK, Kaur K, Chauhan S, Saini A. Gold nanoparticles assisted co-delivery of nisin and doxorubicin against murine skin cancer. Journal of Drug Delivery Science and Technology 2019;53:101147. [DOI: 10.1016/j.jddst.2019.101147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
7 Haider T, Pandey V, Behera C, Kumar P, Gupta PN, Soni V. Spectrin conjugated PLGA nanoparticles for potential membrane phospholipid interactions: Development, optimization and in vitro studies. Journal of Drug Delivery Science and Technology 2020;60:102087. [DOI: 10.1016/j.jddst.2020.102087] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 S S, S R. Cyclic peptide production from lactic acid bacteria (LAB) and their diverse applications. Crit Rev Food Sci Nutr 2020;:1-20. [PMID: 33356473 DOI: 10.1080/10408398.2020.1860900] [Reference Citation Analysis]
9 Daba GM, Elkhateeb WA. Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: Current applications and future prospects. Biocatalysis and Agricultural Biotechnology 2020;28:101750. [DOI: 10.1016/j.bcab.2020.101750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
10 Huang F, Teng K, Liu Y, Cao Y, Wang T, Ma C, Zhang J, Zhong J. Bacteriocins: Potential for Human Health. Oxid Med Cell Longev 2021;2021:5518825. [PMID: 33936381 DOI: 10.1155/2021/5518825] [Reference Citation Analysis]
11 Ahmadi S, Ghollasi M, Hosseini HM. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microbial Pathogenesis 2017;111:193-7. [DOI: 10.1016/j.micpath.2017.08.037] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
12 Dullius A, Rocha CM, Laufer S, de Souza CFV, Goettert MI. Are peptides a solution for the treatment of hyperactivated JAK3 pathways? Inflammopharmacology 2019;27:433-52. [PMID: 30929155 DOI: 10.1007/s10787-019-00589-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Anjana, Tiwari SK. Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota. Front Cell Infect Microbiol 2022;12:851140. [DOI: 10.3389/fcimb.2022.851140] [Reference Citation Analysis]
14 Caballero AM, Villagrán VAS, Serna AJ, Farrés A. Challenges in the production and use of probiotics as therapeuticals in cancer treatment or prevention. J Ind Microbiol Biotechnol 2021:kuab052. [PMID: 34427674 DOI: 10.1093/jimb/kuab052] [Reference Citation Analysis]
15 Rodrigues G, Silva GGO, Buccini DF, Duque HM, Dias SC, Franco OL. Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection. Front Microbiol 2019;10:1690. [PMID: 31447795 DOI: 10.3389/fmicb.2019.01690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
16 Lewies A, Plessis LHD, Wentzel JF. The Cytotoxic, Antimicrobial and Anticancer Properties of the Antimicrobial Peptide Nisin Z Alone and in Combination with Conventional Treatments. In: Çelik TA, editor. Cytotoxicity. InTech; 2018. [DOI: 10.5772/intechopen.71927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 López-cuellar MDR, Rodríguez-hernández A, Chavarría-hernández N. LAB bacteriocin applications in the last decade. Biotechnology & Biotechnological Equipment 2016;30:1039-50. [DOI: 10.1080/13102818.2016.1232605] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
18 Vitale I, Yamazaki T, Wennerberg E, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends Cancer 2021;7:557-72. [PMID: 33446447 DOI: 10.1016/j.trecan.2020.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Preet S, Kaur J, Raza K. Nisin loaded carbopol gel against Pseudomonas aeruginosa infected third-degree burns: A therapeutic intervention. Wound Repair Regen 2021;29:711-24. [PMID: 33721379 DOI: 10.1111/wrr.12909] [Reference Citation Analysis]
20 van Staden ADP, van Zyl WF, Trindade M, Dicks LMT, Smith C. Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings. Appl Environ Microbiol 2021;87:e0018621. [PMID: 33962984 DOI: 10.1128/AEM.00186-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Baindara P, Mandal SM. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie 2020;177:164-89. [PMID: 32827604 DOI: 10.1016/j.biochi.2020.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 El-Sayed Ibrahim N, Morsy H, Abdelgwad M. The Comparative Effect of Nisin and Thioridazine as Potential Anticancer Agents on Hepatocellular Carcinoma. Rep Biochem Mol Biol 2021;9:452-62. [PMID: 33969139 DOI: 10.52547/rbmb.9.4.452] [Reference Citation Analysis]
23 Rana K, Sharma R, Preet S. Augmented therapeutic efficacy of 5-fluorouracil in conjunction with lantibiotic nisin against skin cancer. Biochem Biophys Res Commun 2019;520:551-9. [PMID: 31615654 DOI: 10.1016/j.bbrc.2019.10.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
24 Kaur S, Kaur S. Bacteriocins as Potential Anticancer Agents. Front Pharmacol 2015;6:272. [PMID: 26617524 DOI: 10.3389/fphar.2015.00272] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
25 Zgheib H, Drider D, Belguesmia Y. Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances. Int J Environ Res Public Health 2020;17:E7835. [PMID: 33114656 DOI: 10.3390/ijerph17217835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol 2016;120:1449-65. [PMID: 26678028 DOI: 10.1111/jam.13033] [Cited by in Crossref: 201] [Cited by in F6Publishing: 169] [Article Influence: 33.5] [Reference Citation Analysis]
27 Karpiński TM, Adamczak A. Anticancer Activity of Bacterial Proteins and Peptides. Pharmaceutics 2018;10:E54. [PMID: 29710857 DOI: 10.3390/pharmaceutics10020054] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
28 Goudarzi F, Asadi A, Afsharpour M, Jamadi RH. In Vitro Characterization and Evaluation of the Cytotoxicity Effects of Nisin and Nisin-Loaded PLA-PEG-PLA Nanoparticles on Gastrointestinal (AGS and KYSE-30), Hepatic (HepG2) and Blood (K562) Cancer Cell Lines. AAPS PharmSciTech 2018;19:1554-66. [PMID: 29470827 DOI: 10.1208/s12249-018-0969-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]